Published Online-First

Published: 2024-12-31

Review

IgM Myeloma: A Comprehensive Overview and Practical Approach to Chemotherapeutic Management

Hadeel Elwaheidi, Alaa Hamad, Farah Salameh, Fadwa Elkordy, Rojina FathAlrahman, Amr Hanbali
- HTML
- PDF
DOI: https://doi.org/10.14740/wjon2611

Original Article

Invasive Lobular Carcinoma Has Higher Immune Response Than Invasive Ductal Carcinoma in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers

Gabrielle Yee, Rongrong Wu, Takashi Ishikawa, Kazuaki Takabe
- HTML
- PDF
- Suppl1
DOI: https://doi.org/10.14740/wjon2529
Association Between Platelet-to-Lymphocyte Ratio and Insulin Resistance in Cancer Survivors: A Cross-Sectional Study Based on the NHANES 2005 - 2018

Jiao Wang, Tao Li
- HTML
- PDF
- Suppl1
DOI: https://doi.org/10.14740/wjon2603
Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients

Shereef Ahmed Elsamany, Omima Elemam, Faiza Hassanin, Aboelkhair Algahami, Hossam Alghanmi, Khaled Abd Elaziz Ahmed El naghi
- HTML
- PDF
DOI: https://doi.org/10.14740/wjon2546
Demographic Variations in Immune Checkpoint Inhibitor Adverse Events: A Real-World Study

Shreya Shambhavi, Mariela DiVanna, Shubhangi Sharma, Harmanjeet Singh, Arushi Gupta, Tiffany Pompa, Adam Kaplan, Jose Iglesias
- HTML
- PDF
- Suppl1
- Suppl2
DOI: https://doi.org/10.14740/wjon2612